J Korean Soc Radiol.  2018 Oct;79(4):237-241. 10.3348/jksr.2018.79.4.237.

Palliative Transcatheter Arterial Chemoembolization for Relieving Metastatic Bone Pain due to Hepatocellular Carcinoma: A Case Report

• Ryu HJ
• Moon SN
• Chang NK

• KMID: 2421228
• DOI: http://doi.org/10.3348/jksr.2018.79.4.237

Abstract

Bone metastasis is the third most common extrahepatic metastasis from hepatocellular carcinoma (HCC), following lung and lymph node metastasis. Although transcatheter arterial chemoembolization (TACE) is widely used for the treatment for unresectable HCC in the liver, its effects on bone metastasis from HCC have not been well described in past literature. We report a case of a patient with a metastatic bone lesion from an HCC treated with TACE. After the procedure, the patient's pain and narcotic requirement significantly decreased without major complications.

MeSH Terms

Bone Neoplasms
Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic
Humans
Liver
Lung
Lymph Nodes
Neoplasm Metastasis

Figure

• 

  Fig. 1 TACE of symptomatic bone metastasis from hepatocellular carcinoma in a 66-year-old man. A-C. In the selective arteriogram of the right intercostobronchial trunk (A), right 3rd (B), 4th and 5th (C) intercostal arteries, tumoral staining that correspond to the bone metastasis are seen. D. Completion angiogram after TACE using chemomixure of Adriamycin and lipiodol and gelfoam particle reveals > 75% reduction of tumor blush, which means technical success. TACE = transcatheter arterial chemoembolization TACE of symptomatic bone metastasis from hepatocellular carcinoma in a 66-year-old man. E. On follow-up CT after 3 months of TACE (right), size of the mass narrowing T3 spinal canal decreases and marginal shape of the mass changes to concave compared to CT before TACE (left). TACE = transcatheter arterial chemoembolization

• 

  Fig. 2 Total number of medication decreased with improved patient's pain after TACE as depicted in this graph. TACE = transcatheter arterial chemoembolization

Reference

1.Ferlay J., Shin HR., Bray F., Forman D., Mathers C., Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBO-CAN 2008. Int J Cancer. 2010. 127:2893–2917.

2.Fukutomi M., Yokota M., Chuman H., Harada H., Zaitsu Y., Funakoshi A, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2001. 13:1083–1088.

3.Koike Y., Takizawa K., Ogawa Y., Muto A., Yoshimatsu M., Yagi-hashi K, et al. Transcatheter arterial chemoembolization (TACE) or embolization (TAE) for symptomatic bone metastases as a palliative treatment. Cardiovasc Intervent Radiol. 2011. 34:793–801.

4.Chiras J., Adem C., Vallée JN., Spelle L., Cormier E., Rose M. Selective intra-arterial chemoembolization of pelvic and spine bone metastases. Eur Radiol. 2004. 14:1774–1780.

5.Kato T., Nemoto R., Mori H., Takahashi M., Harada M. Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs. Cancer. 1981. 48:674–680.

6.Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997. 69:1–18.

7.Stein C. Opioids, sensory systems and chronic pain. Eur J Pharmacol. 2013. 716:179–187.

8.Uemura A., Fujimoto H., Yasuda S., Osaka I., Goto N., Shinozaki M, et al. Transcatheter arterial embolization for bone metastases from hepatocellular carcinoma. Eur Radiol. 2001. 11:1457–1462.

9.Barton PP., Waneck RE., Karnel FJ., Ritschl P., Kramer J., Lechner GL. Embolization of bone metastases. J Vasc Interv Radiol. 1996. 7:81–88.

10.Sun S., Lang EV. Bone metastases from renal cell carcinoma: preoperative embolization. J Vasc Interv Radiol. 1998. 9:263–269.